Home › Funds › SECTORAL ASSET MANAGEMENT INC › TARS
SECTORAL ASSET MANAGEMENT INC position in TARS
TARSUS PHARMACEUTICALS INC · Health Care
SECTORAL ASSET MANAGEMENT INC reported holding 13,285 shares of TARS (TARSUS PHARMACEUTICALS INC) in its Q2 2026 13F filing — a position valued at US$836K, representing 0.58% of its reported portfolio and ranking #45 among its reported holdings. SECTORAL ASSET MANAGEMENT INC has disclosed TARS holdings in 8 of the last 8 reported quarters, going back to Q3 2024.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How SECTORAL ASSET MANAGEMENT INC's TARS position evolved
SECTORAL ASSET MANAGEMENT INC first disclosed a stake in TARS in Q3 2024 at 11,300 shares (US$372K). The position peaked in Q4 2025 at 14,740 shares, worth US$1.2M. Across 8 filings, SECTORAL ASSET MANAGEMENT INC increased the stake 3 time(s), trimmed it 4 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 13,285 shares valued at US$836K — an increase of 2,013 shares quarter over quarter.. Notable position changes include a 80% increase in Q4 2024 (shares fell 7% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2024 | 11.30K | $371.66K | New |
| Q4 2024 | 20.30K | $1.12M | Add |
| Q1 2025 | 17.25K | $886.13K | Reduce |
| Q2 2025 | 18.54K | $750.85K | Add |
| Q3 2025 | 18.41K | $1.09M | Reduce |
| Q4 2025 | 14.74K | $1.21M | Reduce |
| Q1 2026 | 11.27K | $852.46K | Reduce |
| Q2 2026 | 13.29K | $836.16K | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About TARS and 13F data
TARS (TARSUS PHARMACEUTICALS INC) is a Health Care company. 40 other funds we track also report a position in TARS — the largest reported positions include Deep Track Capital, LP (US$230.8M), RTW INVESTMENTS, LP (US$211.3M), Paradigm Biocapital Advisors LP (US$174.7M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding TARS
- Deep Track Capital, LP 3.67M sh · $230.79M · Q2 2026
- RTW INVESTMENTS, LP 3.36M sh · $211.29M · Q2 2026
- Paradigm Biocapital Advisors LP 2.78M sh · $174.70M · Q2 2026
- TANG CAPITAL MANAGEMENT LLC 1.57M sh · $98.71M · Q2 2026
- Vestal Point Capital, LP 1.05M sh · $66.09M · Q2 2026
- Frazier Life Sciences Management, L.P. 728.64K sh · $45.86M · Q2 2026
- Tri Locum Partners LP 328.34K sh · $20.67M · Q2 2026
- MPM BioImpact LLC 322.01K sh · $20.27M · Q2 2026
More on SECTORAL ASSET MANAGEMENT INC
FAQ
How long has SECTORAL ASSET MANAGEMENT INC held TARS?
SECTORAL ASSET MANAGEMENT INC has disclosed TARS holdings in 8 of the last 8 reported quarters, going back to Q3 2024.
What is SECTORAL ASSET MANAGEMENT INC's current position in TARS?
As of Q2 2026, SECTORAL ASSET MANAGEMENT INC holds 13.29K shares of TARS (TARSUS PHARMACEUTICALS INC), valued at $836.16K, representing 0.58% of its reported portfolio and ranking #45.
Has SECTORAL ASSET MANAGEMENT INC been buying or selling TARS?
In the latest 13F filing (Q2 2026), SECTORAL ASSET MANAGEMENT INC increased its position in TARS. The position peaked in Q4 2025 at 14.74K shares.
Which other funds hold TARS?
Other major institutional holders of TARS include Deep Track Capital, LP, RTW INVESTMENTS, LP, Paradigm Biocapital Advisors LP, among 40 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.